Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Cognitive Motivational Behavior Therapy for Gamblers

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Edelgard Wulfert, University at Albany
ClinicalTrials.gov Identifier:
NCT00069420
First received: September 24, 2003
Last updated: December 30, 2013
Last verified: December 2013
  Purpose

This study will evaluate the effectiveness of cognitive motivational behavior therapy (CMBT) in treating pathological gamblers.


Condition Intervention Phase
Gambling
Behavioral: Cognitive Motivational Behavior Therapy
Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Cognitive-Motivational Behavior Therapy for Gamblers

Further study details as provided by University at Albany:

Estimated Enrollment: 40
Study Start Date: September 2003
Study Completion Date: May 2007
Primary Completion Date: January 2007 (Final data collection date for primary outcome measure)
Detailed Description:

Pathological gambling is developing into a serious public health problem. The rise in gambling problems has stimulated treatment studies, but little progress has been made. A particular concern is the high dropout rates from treatment studies; gamblers often seek treatment, but fail to complete it and relapse. This study will test the effectiveness of CMBT in helping to increase retention rates in gambling treatment studies.

The first step in this study is designed to enhance gamblers' readiness for change. When participants are committed to change, CMBT will then address specific cognitive biases regarding the notion of randomness, which is thought to lie at the heart of gambling problems. Behavioral components will also be used to enhance gamblers' coping skills.

The participants in this study will be randomly assigned to either CMBT or a Gambler's Anonymous control group. Participants will be assessed prior to and after treatment and at 3- and 6-month follow-up visits. Interviews and questionnaires will be used to assess participants.

  Eligibility

Ages Eligible for Study:   17 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • DSM-IV criteria for pathological gambling
  • Eighth grade reading ability
  • Reside in the Albany, NY area

Exclusion Criteria:

  • Diagnosis of serious psychopathology, including psychosis, bipolar disorder, or alcohol or other substance dependence
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00069420

Locations
United States, New York
University at Albany - SUNY
Albany, New York, United States, 12222
Sponsors and Collaborators
University at Albany
  More Information

No publications provided

Responsible Party: Edelgard Wulfert, Dean, College of Arts & Sciences, University at Albany
ClinicalTrials.gov Identifier: NCT00069420     History of Changes
Other Study ID Numbers: R21 MH64568, R21MH064568, DSIR AT-AS
Study First Received: September 24, 2003
Last Updated: December 30, 2013
Health Authority: United States: Federal Government

ClinicalTrials.gov processed this record on November 20, 2014